Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial

Andreas Diacon, Sachiko Miyahara, Rodney Dawson, Xin Sun, Evelyn Hogg, Kathleen Donahue, Michael Urbanowski, Veronique De Jager, Courtney V. Fletcher, Richard Hafner, Susan Swindells, William Bishai

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences